Investors are rewarding Goleta’s medical device producers as share prices climb for both oxygen concentrator company Inogen and breast implant developer Sientra. After a turbulent 2016, Sientra has moved steadily back toward manufacturing and expanded its portfolio of products, garnering gains in its stock. Shares hit double digits July 11, the highest it’s been since…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
